Routine laboratory parameters predict serious outcome as well as length of hospital stay in COVID-19

Mohammed A Jeraiby1, Majed I Hakamy1, Mohammed B Albarqi1

  • 1From the Department of Medical Biochemistry (Jeraiby, Iqbal), Faculty of Medicine, Jazan University, from the Department of Pulmonology (Hakamy, Albarqi, Areda); and from the Department of Laboratory Medicine (Haddad), King Fahad Central Hospital, Jazan, Kingdom of Saudi Arabia.

Saudi Medical Journal
|November 4, 2021
PubMed

Insights

C-reactive protein (CRP) is a better predictor of serious outcomes in COVID-19 patients than red cell distribution width (RDW) and neutrophil lymphocyte ratio (NLR). CRP also positively correlates with length of hospital stay (LOS), while mean corpuscular hemoglobin concentration (MCHC) shows a negative association.

Area of Science:

  • Clinical Medicine
  • Infectious Diseases
  • Laboratory Hematology

Background:

  • Hospitalized coronavirus disease-19 (COVID-19) patients face risks of serious outcomes and prolonged hospital stays.
  • Biomarkers such as C-reactive protein (CRP), red cell distribution width (RDW), and neutrophil lymphocyte ratio (NLR) are routinely measured and may indicate disease severity.

Purpose of the Study:

  • To validate the predictive capabilities of CRP, RDW, and NLR for serious outcomes in COVID-19 patients.
  • To assess the association of these laboratory markers with the length of hospital stay (LOS) in hospitalized COVID-19 patients.

Main Methods:

  • Retrospective cohort study involving 74 adult COVID-19 patients.
  • Logistic regression and receiver operating curve analysis were used to evaluate risk factors for serious outcomes.
  • Multiple regression analysis determined the association between routine laboratory analytes and LOS.

Main Results:

  • Higher levels of CRP, white blood cells, and neutrophils were observed in patients with serious outcomes.
  • CRP and RDW demonstrated significant predictive value for serious outcomes in both unadjusted and adjusted models.
  • CRP showed a positive association with LOS, while mean corpuscular hemoglobin concentration (MCHC) exhibited a negative association.

Conclusions:

  • C-reactive protein (CRP) is a more effective predictor of serious outcomes in COVID-19 patients compared to RDW and NLR.
  • CRP levels are positively correlated with the length of hospital stay, indicating a potential link to disease duration.
  • Mean corpuscular hemoglobin concentration (MCHC) is negatively associated with LOS, suggesting a possible protective role or different disease trajectory.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
523
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
43
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
497
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
22
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
804
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
82